Skip to Main Content

Paper Details

The OncoMasTR Test Predicts Distant Recurrence in Estrogen Receptor-Positive, HER2-Negative Early-Stage Breast Cancer: A Validation Study in ABCSG Trial 8.
Clin Cancer Res
1
2021
Author NameAffiliation
William M Gallagher
William M GallagherUCD Conway Institute of Biomolecular and Biomedical Science, University College Dublin
  • 1 - 2

Datasets

Release 1.2